AI in Biotechnology: Global Markets

Report Code: AIT016A

Publish Date: Aug 2025

Publisher: BCC Publishing

Category: AI Technology

Download Report Overview

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for AI in biotechnology was valued at $3.8 billion in 2024. The market is estimated to grow from $4.6 billion in 2025 to $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 20% from 2025 to 2030.

Report Includes

  • 50 data tables and 57 additional tables
  • An analysis of the current and future global markets for artificial intelligence (AI) in biotechnology
  • Analyses of the global market trends, with historic revenue data (sales figures) from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
  • Estimates of the size of the market and revenue prospects, along with a corresponding market share analysis based on product type, application, deployment type, end user, and region
  • Facts and figures pertaining to market dynamics, technological advancements, regulations, prospects and the impact of macroeconomic variables
  • Discussion of the underlying opportunities and potential, with the development of novel products, drug discovery, clinical trials and other related applications
  • Insights derived from Porter’s Five Forces model and global supply chain analyses
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Profiles of the leading companies, including NVIDIA Corp., Tempus AI Inc., Recursion Pharmaceuticals, Schrödinger Inc., and Sophia Genetics

Report Scope

The report analyzes the trends in the global market for AI in biotechnology. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The market is segmented by product type (software and services), deployment (cloud-based and on-premises), application and end user. Applications consist of drug discovery, clinical trials, diagnostics and others. End users consist of pharmaceutical and biotech companies, academic research institutes, contract R&D organizations (CROs/CDMOs) and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the Rest of Europe, China, Japan, India, South Korea and the Rest of Asia-Pacific.

The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. It offers company profiles that covers such details as financials, product portfolio and recent developments. It analyzes companies’ environmental, social and corporate governance (ESG) initiatives.

Report Synopsis

Report Metrics Details
Base year considered 2024
Forecast period considered 2025-2030
Base year market size $3.8 Billion
Market size forecast $11.4 Billion
Growth rate CAGR of 20.0% from 2025 to 2030
Units considered $ Millions
Segments covered By Product Type, Application, Deployment Type, End User, and Region
Regions covered North America, Europe, Asia-Pacific and the Rest of World (RoW)
Key Market Drivers
  • Need for a more effective drug discovery and development process.
  • Trend toward personalized medicine.
  • Growing demand for early diagnosis.
  • Investments in AI in biopharmaceuticals.
  • Aging population leading to increased prevalence of chronic diseases.
Companies studied
ABCELLERA BIOLOGICS INC.ABSCI CORP.
ATOMWISE INC.BENEVOLENTAI
DNANEXUS INC.EUROFINS SCIENTIFIC
ILLUMINA INC.INSILICO MEDICINE
NVIDIA CORP.QIAGEN
RECURSIONSCHRODINGER INC.
SOPHIA GENETICSTEMPUS AI INC.
XTALPI INC.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The AI in the biotechnology market is estimated to be around $3.8 billion in 2024 and is expected to grow at a CAGR of 20.0% over the forecast period, reaching a value of $11.4 billion in 2030.
The global market for AI in the biotechnology is growing due to demand for effective drug discovery and development process, increasing investments in the biopharmaceutical research and development, demand for effective diagnosis and personalized therapies, and increasing prevalence of chronic diseases.
The global market for AI in the biotechnology is restrained by factors such as data quality and bias, ethical concerns, and hurdles of integration.
The global market for AI in the biotechnology growth opportunities includes adoption of AI in synthetic biology and convergence of AI and quantum computing.
The global market for AI in biotechnology is segmented by product type, deployment, application, end-user, and region.
The drug discovery segment will dominate the market in 2030.
North America holds the highest share of the market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: AI in Biotechnology: Global Markets142Free
Chapter- 1: Executive Summary5Free
Chapter- 2: Market Overview11Free
Chapter- 3: Market Dynamics8Free
Chapter- 4: Regulatory Landscape3Free
Chapter- 5: Emerging Technologies and Developments3Free
Chapter- 6: Market Segmentation Analysis42Free
Chapter- 7: Competitive Intelligence12Free
Chapter- 8: Sustainability in AI in Biotechnology Market: An ESG Perspective3Free
Chapter- 9: Appendix55Free

Related Reports

Global Markets for Catheters

Published - Dec 2025 | Publisher - BCC Publishing | Code - HLC019K

The global market for catheters is expected to grow from $22.8 billion in 2025 and is projected to reach $36 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.6% during the forecast period of 2025 to 2030.

AI in Agriculture: Global Markets

Published - Nov 2025 | Publisher - BCC Publishing | Code - AIT015A

The global market for AI in agriculture is estimated to grow from $2.8 billion in 2025 to reach $8.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.1% from 2025 through 2030.

AI Use Case Analysis: Global Outlook

Published - Oct 2025 | Publisher - BCC Publishing | Code - AIT002B

This report provides an overview of emerging artificial intelligence (AI) technologies and their applications across various industries. It covers emerging AI technologies and their applications and use cases in several industry verticals.

Artificial Intelligence (AI) in Pharmaceuticals: Global Markets

Published - Sep 2025 | Publisher - BCC Publishing | Code - AIT020A

The global market for artificial intelligence (AI) in pharmaceuticals is estimated to grow from $3.8 billion in 2025 to reach $15.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 31.7% from 2025 through 2030.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 107

  • Summary Table: Global Market for AI in Biotechnology, by Region, Through 2030
  • Table 1: Applications of AI in Biotechnology
  • Table 2: Global Incidence and Mortality Cancer Rates, by WHO Region, 2022
  • Table 3: Global Market for AI in Biotechnology, by Product Type, Through 2030
  • Table 4: Software Platforms
  • Table 5: Global Market for AI Software in Biotechnology, by Region, Through 2030
  • Table 6: Global Market for AI in Biotechnology Services, by Region, Through 2030
  • Table 7: Global Market for AI in Biotechnology, by Deployment, Through 2030
  • Table 8: Global Market for Cloud Deployments for AI in Biotechnology, by Region, Through 2030
  • Table 9: Global Market for On-Premises Deployments for AI in Biotechnology, by Region, Through 2030
  • Table 10: Global Market for AI in Biotechnology, by Application, Through 2030
Sample Report

Recent Reports

AI Impact on Central Nervous System (CNS) Biomarkers: Technologies and Global Markets – BCC Pulse Report

Published - Jan 2026 | Publisher - BCC Publishing | Code - AIT089A

AI is beginning to transform the discovery, validation and application of central nervous system (CNS) biomarkers in clinical practice. AI accelerates biomarker development by analyzing large-scale datasets to support faster validation studies and regulatory submissions. AI also positioning CNS biomarkers not only as diagnostic tools but as intelligent, data-driven solutions that enhance clinical decision-making, patient access and healthcare efficiency in neurology.

AI Impact on Cloud Computing in Cell Biology, Genomics and Drug Development - BCC Pulse Report

Published - Jan 2026 | Publisher - BCC Publishing | Code - AIT087A

AI is reshaping cloud computing in cell biology, genomics and drug development, extending the existing potential of computational and experimental methods. AI helps address the industry's pain points, including lengthy timelines for discovery, high attrition rates during drug development, and ineffective design and execution of clinical trials. The combination of AI and cloud improves global collaboration by providing a compliant way to directly connect research institutes, biopharma companies and clinical sites.

AI Impact on Diabetes Therapeutics and Diagnostics Market - BCC Pulse Report

Published - Dec 2025 | Publisher - BCC Publishing | Code - AIT091A

This report provides an outlook of AI impact on the global diabetes therapeutics and diagnostics market. It highlights major AI adoption trends across the major geographic regions, and disruptions caused by AI in several key industry verticals.

AI Impact on Negative Pressure Wound Therapy (NPWT) Devices Market - BCC Pulse Report

Published - Dec 2025 | Publisher - BCC Publishing | Code - AIT090A

This report provides an outlook of AI impact on the negative pressure wound therapy (NPWT) devices market. It highlights major AI adoption trends across the major geographic regions, and disruptions caused by AI in several key industry verticals.

AI Impact on Genetic Modification Therapies Market - BCC Pulse Report

Published - Dec 2025 | Publisher - BCC Publishing | Code - AIT088A

AI is revolutionizing gene therapy by enabling more precise, efficient and personalized treatments. AI tools analyze large genomic datasets, identify potential gene targets and predict the outcomes of genetic modifications. It shows impressive pattern recognition, data processing and decision-making ability, especially in ML and deep learning (DL) algorithms.

Top Trending Reports

Global GLP-1 Analogues Market

Published - Dec 2025 | Publisher - BCC Publishing | Code - PHM289A

This report presents detailed information on glucagon-like peptide-1 (GLP-1) analogues. It examines market trends for GLP-1 analogues using data from 2024, estimates for 2025, and projected compound annual growth rates (CAGRs) through 2030 (the forecast period of 2025–2030). The report also covers regional markets for GLP-1 analogues. The GLP-1 analogue market is segmented by route of administration into oral and injection. By region, the market is divided into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.

Data Center Networking Technologies: Global Markets

Published - Dec 2025 | Publisher - BCC Publishing | Code - IFT103C

The global market for data center networking technologies is expected to grow from $45.8 billion in 2025 and is projected to reach $103 billion by the end of 2030, at a compound annual growth rate (CAGR) of 17.6% during the forecast period of 2025 to 2030.

Protein Expression: Global Markets

Published - Nov 2025 | Publisher - BCC Publishing | Code - BIO165B

The global market for protein expression is estimated to grow from $4.7 billion in 2025 to reach $7.9 billion by 2030, at a compound annual growth rate (CAGR) of 10.9% from 2025 through 2030.

Biofuels: Global Markets

Published - Dec 2025 | Publisher - BCC Publishing | Code - EGY064F

The global market for biofuels is expected to grow from $150.9 billion in 2025 to reach $194.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 5.2% from 2025 through 2030.

Global Data Center Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - IFT320A

The global market for data centers is expected to grow from $418.2 billion in 2025 and is projected to reach $691.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
AI in Biotechnology: Global Markets
Sample Report
AI Sentiment